Richard brings more than a decade of experience in research to NG Bio, where he is responsible for identifying life changing opportunities and evaluating their scientific and commercial viability as a potential new ventures. Before joining NG Bio, Richard was part of the LifeArc Technology Transfer Fellowship, where he held a similar role.

Richard has conducted research across several disciplines during his academic career. Still, his passion is understanding the fundamentals of the human genome and how its regulation shapes the function and development of cells and tissues. However, Richard’s broad experience and interest in fundamental biology and the biopharma industry give him the tools necessary to effectively identify great opportunities.

Richard earned a PhD in developmental genetics and a post-doctoral fellowship at The Francis Crick Institute, London. Most recently, he obtained a master’s degree in Finance, where he completed research on the role of acquisitions in shaping innovative output in the biopharma industry.